Literature DB >> 20929366

Prevention of healthcare‐associated Clostridium difficile infection: what works?

Erik R Dubberke1.   

Abstract

Prevention of Clostridium difficile infection has become extremely important because of increases in its incidence and severity. Unfortunately, efforts at C. difficile infection prevention are hampered by lack of data to support optimal prevention methods, especially for endemic C. difficile infection. Studies are needed to define the optimal prevention practices and to investigate novel prevention methods.

Entities:  

Mesh：

Year:  2010        PMID： 20929366      PMCID： PMC3648222          DOI： 10.1086/655985

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  20 in total

1.  An intervention to decrease catheter-related bloodstream infections in the ICU.

Authors:  Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel
Journal:  N Engl J Med       Date:  2006-12-28       Impact factor: 91.245

2.  Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain.

Authors:  Louis Valiquette; Benoit Cossette; Marie-Pierre Garant; Hassan Diab; Jacques Pépin
Journal:  Clin Infect Dis       Date:  2007-09-01       Impact factor: 9.079

3.  Strategies to prevent clostridium difficile infections in acute care hospitals.

Authors:  Erik R Dubberke; Dale N Gerding; David Classen; Kathleen M Arias; Kelly Podgorny; Deverick J Anderson; Helen Burstin; David P Calfee; Susan E Coffin; Victoria Fraser; Frances A Griffin; Peter Gross; Keith S Kaye; Michael Klompas; Evelyn Lo; Jonas Marschall; Leonard A Mermel; Lindsay Nicolle; David A Pegues; Trish M Perl; Sanjay Saint; Cassandra D Salgado; Robert A Weinstein; Robert Wise; Deborah S Yokoe
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

4.  A multicenter intervention to prevent catheter-associated bloodstream infections.

Authors:  David K Warren; Sara E Cosgrove; Daniel J Diekema; Gianna Zuccotti; Michael W Climo; Maureen K Bolon; Jerome I Tokars; Gary A Noskin; Edward S Wong; Kent A Sepkowitz; Loreen A Herwaldt; Trish M Perl; Steven L Solomon; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2006-06-09       Impact factor: 3.254

5.  Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.

Authors:  S Fowler; A Webber; B S Cooper; A Phimister; K Price; Y Carter; C C Kibbler; A J H Simpson; S P Stone
Journal:  J Antimicrob Chemother       Date:  2007-03-26       Impact factor: 5.790

6.  An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center.

Authors:  David K Warren; Jeanne E Zack; Michael J Cox; Max M Cohen; Victoria J Fraser
Journal:  Crit Care Med       Date:  2003-07       Impact factor: 7.598

7.  The A, B, BI, and Cs of Clostridium difficile.

Authors:  Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

8.  Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.

Authors:  Sarah K Abbett; Deborah S Yokoe; Stuart R Lipsitz; Angela M Bader; William R Berry; Elise M Tamplin; Atul A Gawande
Journal:  Infect Control Hosp Epidemiol       Date:  2009-11       Impact factor: 3.254

9.  New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration.

Authors:  Michelle M Merrigan; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  Int J Antimicrob Agents       Date:  2009-03       Impact factor: 5.283

10.  Clostridium difficile in retail meat products, USA, 2007.

Authors:  J Glenn Songer; Hien T Trinh; George E Killgore; Angela D Thompson; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883
View more
  7 in total

1.  Clostridium difficile O27 colitis: hospital-onset but community-acquired.

Authors:  S Buffet-Bataillon; P Tattevin; H Sénéchal; M Cormier; P Vincent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

2.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

3.  Epidemiological model for Clostridium difficile transmission in healthcare settings.

Authors:  C Lanzas; E R Dubberke; Z Lu; K A Reske; Y T Gröhn
Journal:  Infect Control Hosp Epidemiol       Date:  2011-06       Impact factor: 3.254

4.  A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.

Authors:  Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Anaerobe       Date:  2012-12-13       Impact factor: 3.331

5.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

6.  Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.

Authors:  Taojun He; Samuel E Kaplan; Luz A Gomez; Xuedong Lu; Lakshmi V Ramanathan; Mini Kamboj; Yi-Wei Tang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-21       Impact factor: 3.267

Review 7.  Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations.

Authors:  Evelyn Balsells; Teodora Filipescu; Moe H Kyaw; Camilla Wiuff; Harry Campbell; Harish Nair
Journal:  J Glob Health       Date:  2016-12       Impact factor: 4.413
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.